What is the average price target for CELLECTIS - ADR (CLLS) stock?
13 analysts have analysed CLLS and the average price target is 8.08 USD. This implies a price increase of 114.32% is expected in the next year compared to the current price of 3.77.
CELLECTIS - ADR (CLLS) Forecast, Price Target & Analyst Ratings
NASDAQ:CLLS • US15117K1034
Current stock price
3.77 USD
-0.23 (-5.75%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CELLECTIS - ADR (CLLS).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Apr 30, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.28
- Revenue Estimate
- 13.802M
Price Target Details & History
Consensus Price Target and Range
Mean target
$8.08
Upside
+ 114.32%
From current price of $3.77 to mean target of $8.08, Based on 13 analyst forecasts
Low
$8.00
Median
$8.08
High
$8.32
Price Target Revisions
1 Month
6.02%
3 Months
3.70%
Price Target Summary
13 Wall Street analysts provided a forecast for the next 12 months for CLLS. The average price target is 8.08 USD. This implies a price increase of 114.32% is expected in the next year compared to the current price of 3.77.
The average price target has been revised upward by 3.7% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
84.62%
CLLS was analyzed by 13 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about CLLS.
In the previous month the buy percentage consensus was at a similar level.
CLLS was analyzed by 13 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-14 | Citizens | Reiterate | Market Outperform -> Market Outperform |
| 2025-12-23 | Clear Street | Initiate | Buy |
| 2025-10-17 | Barclays | Maintains | Overweight -> Overweight |
| 2025-05-13 | Barclays | Maintains | Overweight -> Overweight |
| 2024-11-05 | Barclays | Maintains | Overweight -> Overweight |
| 2024-06-12 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-05-31 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023-11-01 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023-08-08 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-08-07 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023-04-05 | Citigroup | Maintains | Buy |
| 2023-03-13 | JMP Securities | Reiterate | Market Outperform |
| 2023-03-13 | Oppenheimer | Maintains | Outperform |
| 2023-01-19 | JMP Securities | Maintains | Market Outperform |
| 2022-05-24 | Goldman Sachs | Maintains | Sell |
| 2022-05-18 | Baird | Upgrade | Neutral -> Outperform |
| 2022-05-13 | Barclays | Maintains | Overweight |
| 2022-01-06 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2021-11-30 | JMP Securities | Initiate | Market Outperform |
| 2021-10-08 | Baird | Downgrade | Outperform -> Neutral |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Apr 30, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.28
- Revenue Estimate
- 13.802M
- Revenue Q2Q
- 14.74%
- EPS Q2Q
- -56.36%
- Number of Analysts
- 7
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
-39.26%
EPS (1 Month)
-14.69%
EPS (3 Months)
-2.09%
Next Earnings Summary
CLLS is expected to report earnings on 4/30/2026. The consensus EPS estimate for the next earnings is -0.28 USD and the consensus revenue estimate is 13.80M USD.
The next earnings revenue estimate has been revised downward by 39.26% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
Full Analyst Estimates 2026 - 2032
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 9.193M -64.26% | 49.217M 435.37% | 79.592M 61.72% | 58.422M -26.60% | 58.993M 0.98% | 28.325M -51.99% | 83.011M 193.07% | 186.82M 125.05% | 224.24M 20.03% | 296.41M 32.18% | |
| EBITDA YoY % growth | -78.779M -10.60% | -39.708M 49.60% | -13.014M 67.23% | -106.09M -715.20% | -121.54M -14.56% | -183.463M -50.95% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -97.302M -8.52% | -59.554M 38.79% | -33.076M 44.46% | -89.522M -170.66% | -147.259M -64.49% | -43.229M 70.64% | -98.689M -128.29% | 50.869M 151.54% | 87.024M 71.07% | 137.1M 57.54% | |
| Operating Margin | -1,058.44% | -121.00% | -41.56% | -153.23% | -249.62% | -152.62% | -118.89% | 27.23% | 38.81% | 46.25% | |
| EPS YoY % growth | -1.78 24.77% | -0.35 80.34% | -0.67 -91.43% | -1.09 -63.57% | -1.39 -27.19% | -1.27 8.37% | N/A | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.28 -56.36% | -0.31 -28.21% | -0.25 -2,556.55% | -0.28 -8.28% | -0.28 -0.64% | -0.30 2.93% | -0.08 67.85% | -0.28 1.22% |
| Revenue Q2Q % growth | 13.802M 14.74% | 11.399M -37.34% | 15.296M -58.84% | 21.45M 75.73% | 39.295M 184.71% | 39.81M 249.24% | 105.63M 590.57% | 14.729M -31.33% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -14.691M -3.61% | -16.237M 31.68% | -14.974M -286.22% | -19.426M -108.66% | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-23.99%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
-25.71%
Revenue Next 5 Year
22.01%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
-46.60%
EBIT Next 5 Year
N/A
CELLECTIS - ADR / CLLS Forecast FAQ
When does CELLECTIS - ADR (CLLS) report earnings?
CELLECTIS - ADR (CLLS) will report earnings on 2026-04-30.
Can you provide the consensus estimates for CELLECTIS - ADR next earnings?
The consensus EPS estimate for the next earnings of CELLECTIS - ADR (CLLS) is -0.28 USD and the consensus revenue estimate is 13.80M USD.
How many analysts cover CELLECTIS - ADR (CLLS) stock?
The number of analysts covering CELLECTIS - ADR (CLLS) is 13.